| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 28.260 | 34.985 | 36.669 | 49.793 | 53.508 | 56.591 | 60.145 | 68.952 | 84.101 |
| Total Income - EUR | - | 28.260 | 34.994 | 36.669 | 49.793 | 55.577 | 56.777 | 60.146 | 68.952 | 84.102 |
| Total Expenses - EUR | - | 13.666 | 17.411 | 17.738 | 16.643 | 20.004 | 20.098 | 19.930 | 22.691 | 20.268 |
| Gross Profit/Loss - EUR | - | 14.594 | 17.583 | 18.931 | 33.150 | 35.574 | 36.679 | 40.217 | 46.262 | 63.835 |
| Net Profit/Loss - EUR | - | 14.123 | 17.233 | 18.564 | 32.652 | 35.053 | 36.289 | 39.623 | 45.572 | 61.311 |
| Employees | - | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dermafarm Dr. Gavrilă Elena Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 35 | 495 | 629 | 904 | 1.511 | 1.645 | 1.393 | 1.176 |
| Current Assets | - | 14.987 | 18.572 | 37.393 | 47.164 | 37.576 | 36.399 | 39.931 | 46.289 | 101.316 |
| Inventories | - | 0 | 195 | 356 | 349 | 342 | 387 | 490 | 551 | 548 |
| Receivables | - | 1.861 | 2.330 | 459 | 3.839 | 4.921 | 5.124 | 16.620 | 10.173 | 43.806 |
| Cash | - | 13.126 | 16.048 | 36.579 | 42.976 | 32.313 | 30.888 | 22.822 | 35.565 | 56.962 |
| Shareholders Funds | - | 14.036 | 17.459 | 35.703 | 45.481 | 35.107 | 36.453 | 39.791 | 45.821 | 61.543 |
| Social Capital | - | 45 | 44 | 43 | 42 | 45 | 44 | 45 | 44 | 44 |
| Debts | - | 951 | 1.148 | 2.186 | 2.312 | 3.373 | 1.457 | 1.785 | 1.861 | 40.949 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermafarm Dr. Gavrilă Elena Srl